Methodological Evolution: Phage Display and Transgenic Dominance
The choice of discovery technology is a critical determinant of market success in 2025. According to a Antibody Drug Discovery Market Analysis, the Phage Display segment continues to dominate the technical landscape, projected to account for a 50.3% share by 2035. Its popularity stems from its ability to produce high-affinity human antibodies rapidly without the ethical and logistical hurdles...
0 التعليقات 0 المشاركات 9 مشاهدة 0 معاينة